Neuregulin-1 enhances depolarization-induced GABA release
Ran-Sook Woo1, Xiao-Ming Li, Yanmei Tao
1Program of Developmental Neurobiology, Institute of Molecular Medicine and Genetics, Department of Neurology, Medical College of Georgia, Augusta, GA 30912, USA.
Neuron
|May 25, 2007
Summary
Neuregulin-1 (NRG1) regulates GABAergic transmission via presynaptic ErbB4 receptors in the prefrontal cortex. This finding reveals a novel function for NRG1 and ErbB4, potentially explaining GABAergic dysfunction in schizophrenia.
Area of Science:
- Neuroscience
- Molecular Biology
- Synaptic Plasticity
Background:
- Neuregulin-1 (NRG1) is a known regulator of neural development and excitatory neurotransmission.
- ErbB4, a receptor for NRG1, is present in glutamic acid decarboxylase (GAD)-positive neurons, but its role in GABAergic transmission is largely unknown.
- Both NRG1 and ErbB4 are implicated as susceptibility genes for schizophrenia.
Purpose of the Study:
- To investigate the role of NRG1 and its receptor ErbB4 in regulating GABAergic transmission.
- To determine the localization of ErbB4 at GABAergic terminals.
- To explore the potential implications for understanding schizophrenia pathophysiology.
Main Methods:
- Immunohistochemical localization of ErbB4 at GABAergic terminals in the prefrontal cortex.
- Electrophysiological recordings to assess the effects of endogenous and exogenous NRG1 on GABAergic transmission.
- Pharmacological inhibition and genetic mutation of ErbB4 to confirm its involvement.
Main Results:
- ErbB4 was found to be localized at GABAergic terminals in the prefrontal cortex.
- NRG1 (both endogenous and exogenous) was shown to regulate GABAergic transmission.
- The effects of NRG1 on GABAergic transmission were dependent on ErbB4 activity, as they were blocked by ErbB4 inhibition or mutation.
Conclusions:
- NRG1 regulates GABAergic transmission through presynaptic ErbB4 receptors.
- This study identifies a novel function for NRG1 in modulating inhibitory neurotransmission.
- The findings suggest a potential mechanism linking NRG1/ErbB4 signaling to GABAergic dysfunction in schizophrenia.
Related Concept Videos
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:29Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:21G-Protein Gated Ion Channels
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Sensory organs,...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...